Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

M A Ross

Showing results (71-80 of 79) with videos related to

Pageof 8
Sort By:
You have reached the last page of results.This site can display upto 79 results.
Journal of the Neurological Sciences|January 7, 1998
A brief quality-of-life measure for ALS clinical trials based on a subset of items from the sickness impact profile. The Syntex-Synergen ALS/CNTF Study GroupD McGuire, L Garrison, C Armon, et al.
The American Journal of Cardiology|September 19, 1997
Impact on the care of the emergency department chest pain patient from the chest pain evaluation registry (CHEPER) studyL G Graff, J Dallara, M A Ross, et al.
Neurology|April 1, 1998
Toward earlier diagnosis of amyotrophic lateral sclerosis: revised criteria. rhCNTF ALS Study GroupM A Ross, R G Miller, L Berchert, et al.
Muscle & Nerve|June 1, 1997
Reliability of maximal voluntary isometric contraction testing in a multicenter study of patients with amyotrophic lateral sclerosis. Syntex/Synergen Neuroscience Joint Venture rhCNTF ALS Study GroupR J Hoagland, M Mendoza, C Armon, et al.
Annals of Neurology|February 1, 1996
A placebo-controlled trial of recombinant human ciliary neurotrophic (rhCNTF) factor in amyotrophic lateral sclerosis. rhCNTF ALS Study GroupR G Miller, J H Petajan, W W Bryan, et al.
Amyotrophic Lateral Sclerosis and Other Motor Neuron Disorders : Official Publication of the World Federation of Neurology, Research Group on Motor Neuron Diseases|May 15, 2003
Can we eliminate placebo in ALS clinical trials?W W Bryan, R J Hoagland, J Murphy, et al.
American Journal of Transplantation : Official Journal of the American Society of Transplantation and the American Society of Transplant Surgeons|March 5, 2010
Ex vivo application of carbon monoxide in UW solution prevents transplant-induced renal ischemia/reperfusion injury in pigsJ Yoshida, K S Ozaki, M A Nalesnik, et al.
Neurology|December 1, 1996
Placebo-controlled trial of gabapentin in patients with amyotrophic lateral sclerosis. WALS Study Group. Western Amyotrophic Lateral Sclerosis Study GroupR G Miller, D Moore, L A Young, et al.
Mucosal Immunology|September 19, 2013
Thrombospondin-1 triggers macrophage IL-10 production and promotes resolution of experimental lung injuryY Zhao, Z Xiong, E J Lechner, et al.
Pageof 8

Showing results (71-80 of 79) with videos related to

Sort By:
Pageof 8
You have reached the last page of results.This site can display upto 79 results.
Journal of the Neurological Sciences|January 7, 1998
A brief quality-of-life measure for ALS clinical trials based on a subset of items from the sickness impact profile. The Syntex-Synergen ALS/CNTF Study GroupD McGuire, L Garrison, C Armon, et al.
The American Journal of Cardiology|September 19, 1997
Impact on the care of the emergency department chest pain patient from the chest pain evaluation registry (CHEPER) studyL G Graff, J Dallara, M A Ross, et al.
Neurology|April 1, 1998
Toward earlier diagnosis of amyotrophic lateral sclerosis: revised criteria. rhCNTF ALS Study GroupM A Ross, R G Miller, L Berchert, et al.
Muscle & Nerve|June 1, 1997
Reliability of maximal voluntary isometric contraction testing in a multicenter study of patients with amyotrophic lateral sclerosis. Syntex/Synergen Neuroscience Joint Venture rhCNTF ALS Study GroupR J Hoagland, M Mendoza, C Armon, et al.
Annals of Neurology|February 1, 1996
A placebo-controlled trial of recombinant human ciliary neurotrophic (rhCNTF) factor in amyotrophic lateral sclerosis. rhCNTF ALS Study GroupR G Miller, J H Petajan, W W Bryan, et al.
Amyotrophic Lateral Sclerosis and Other Motor Neuron Disorders : Official Publication of the World Federation of Neurology, Research Group on Motor Neuron Diseases|May 15, 2003
Can we eliminate placebo in ALS clinical trials?W W Bryan, R J Hoagland, J Murphy, et al.
American Journal of Transplantation : Official Journal of the American Society of Transplantation and the American Society of Transplant Surgeons|March 5, 2010
Ex vivo application of carbon monoxide in UW solution prevents transplant-induced renal ischemia/reperfusion injury in pigsJ Yoshida, K S Ozaki, M A Nalesnik, et al.
Neurology|December 1, 1996
Placebo-controlled trial of gabapentin in patients with amyotrophic lateral sclerosis. WALS Study Group. Western Amyotrophic Lateral Sclerosis Study GroupR G Miller, D Moore, L A Young, et al.
Mucosal Immunology|September 19, 2013
Thrombospondin-1 triggers macrophage IL-10 production and promotes resolution of experimental lung injuryY Zhao, Z Xiong, E J Lechner, et al.
Pageof 8